Search Results 111-120 of 16688 for alopecia

1. Steroid profiling in the diagnosis of malignant adrenal masses: Cases from the endocrine teaching clinics

   On physical exam, no features of overt Cushing syndrome, acne, hirsutism, androgenic alopecia or edema were noted. Biochemical workup was consistent with ...

2. First in Human Study of TORL-1-23 in Participants With Advanced Cancer - Mayo Clinic

   ... alopecia or laboratory abnormalities otherwise meeting eligibility requirements * Received prior chemotherapeutic, investigational, or other therapies for ...

3. A Study of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics (PK/PD) in Patients With Hematologic Malignancies - Mayo Clinic

   recover to ≤ Grade 1 except alopecia or neuropathy. 9. Concurrent treatment with an investigational agent, 14 days for small molecular agents and/or 28 ...

4. A Study of BBI608 Combined with Standard Chemotherapies in Adult Patients who have Pancreatic Cancer - Mayo Clinic

   ... alopecia and anemia), or be deemed irreversible; Can have received Gemcitabine-based therapy in an adjuvant setting for Arm A of the trial (Gemcitabine with ...

5. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

   ... alopecia and neuropathy - Patients who are receiving any other investigational agents - History of allergic reactions attributed to compounds of similar ...

6. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder, Telogen ...

7. Publications - Amjad N. Kanj, M.D., M.P.H. - Mayo Clinic

   Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women. Open Forum Infect Dis. 2019 Jul; 6(7):ofz278. Epub 2019 Jun 06. View PubMed ...

8. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

   exception of alopecia, vitiligo, and protocol defined laboratory values. - Participants with Grade ≥2 neuropathy will be evaluated on a case-by-case basis

9. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...

10. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...